NCT06432036 2026-03-06Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE TrialJonsson Comprehensive Cancer CenterPhase 1/2 Recruiting25 enrolled